$LAR

Lithium Argentina to Release PPG Scoping Study Results with Third Quarter 2025 Earnings

ZUG, Switzerland, Nov. 07, 2025 ( GLOBE NEWSWIRE ) -- Lithium Argentina AG ( "Lithium Argentina" or the "Company" ) ( TSX: LAR ) ( NYSE: LAR ) will release its third quarter 2025 earnings results before market open on Monday, November 10, 2025.

Original reporting
GlobeNewswire · Lithium Argentina AG
Published Nov 7, 2025, 9:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 7, 2025, 9:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Lithium Argentina to Release PPG Scoping Study Results with Third Quarter 2025 Earnings — source image
Decision brief

The 30-second read

$LARNeutralMed
01

Why it matters

Positive results could enhance project valuation, attracting investor interest.

02

Market read

The upcoming earnings and study results are relevant for investors in lithium and mining sectors, with potential sector-wide implications.

03

What to watch

Potential geopolitical or macroeconomic factors affecting lithium demand and prices.

Timing: High, as earnings release is imminent.

Background

Lithium Argentina is a key player in lithium extraction, with recent developments including the upcoming release of PPG scoping study results.

Company-level read

Ticker impact

$LARNeutralMedium confidence
Context

Primary focus due to company-specific news.

Expected impact

Potential moderate upward movement post-earnings release.

Evidence & confidence

Earnings reports and scoping study results can impact stock valuation; however, the neutral sentiment indicates no immediate strong directional bias.

Market effects

Potential positive impact on lithium and battery materials sector.

Limited, as the news pertains primarily to a Swiss-based company with Argentina operations.

Moderate, given the global importance of lithium supply chains.

Counterpoint

Earnings may be in line or below expectations, leading to a neutral or negative market reaction.

Key entities

  • Lithium Argentina AG

    A lithium mining company listed on TSX and NYSE.

  • PPG

    Preliminary project evaluation related to lithium extraction.

Related articles

$LARMedAI 8/10

Lithium Argentina Reports Second Quarter 2026 Results

Lithium Argentina AG (TSX/NYSE: LAR) reported Q2 2026 results, citing Cauchari-Olaroz output of 9,280 tonnes of lithium carbonate and near design capacity. Q2 revenue was $174 million, adjusted EBITDA $110 million, operating cash flow $142 million and free cash flow from operations $141 million. Net debt fell $114 million and Stage 2 expansion progress continued under RIGI.

$LARMedAI 8/10

Lithium Argentina AG: Lithium Argentina Announces $220 Million of New Debt Facilities Closed at Cauchari-Olaroz

Lithium Argentina AG (TSX: LAR, NYSE: LAR) said its Cauchari-Olaroz lithium brine operation closed $220 million in unsecured debt facilities to fund flexibility for Stage 2 expansion of 45,000 tonnes per year of lithium carbonate equivalent. The facilities include $50 million (2-year) and $170 million (3-year, interest under 5%), drawdown until Q2 2027, backed by Ganfeng.

$PSXMed

Good news for San Diego drivers? A $5B fuel pipeline project advances

Phillips 66, Kinder Morgan and HF Sinclair said they made a final investment decision to proceed with the $5 billion Western Gateway Pipeline, aiming for completion in 2029 subject to permits. The 1,300-mile system would move refined fuels into the West with 230,000 bpd capacity and potential Southern California gasoline price relief. Ownership: Phillips 66 49.9%, Kinder Morgan 35.1%, HF Sinclair 15%.

Med

Glenmark’s U.S. unit settles Humana antitrust case for $15.3 mln

Glenmark Pharmaceuticals’ U.S. unit said, in an exchange filing, it reached a settlement with Humana to resolve antitrust litigation tied to consolidated generic-drug price-fixing claims in the Eastern District of Pennsylvania. The settlement totals $15.28 million plus interest, paid in two installments. Glenmark denied the allegations and said the amount was already booked in its financial statements.

$PLTRMed

Give Palantir up to $244m through 2028, says internal Defense Department memo

An internal US Defense Department memo reportedly directs subordinates to buy up to $243.9 million in services from Palantir through March 31, 2027, without competitive bidding, and to identify additional funding for April 1, 2027 to Dec. 31, 2028. The memo cites Palantir support for defense industrial base efficiency and munitions/vehicle delays. Palantir is a public company.